NextRNA Therapeutics
Biotechnology ResearchView the employees at
NextRNA Therapeutics-
Rachel U. Data Science and Modeling Co-op at NextRNA Therapeutics | Data Science & Behavioral Neuroscience Student at Northeastern University
-
Boston, Massachusetts, United States
-
Rising Star
Lalit K Sharma, Ph.D. Director, Medicinal Chemistry at NextRNA Therapeutics-
Cambridge, Massachusetts, United States
-
Top 5%
Ahmed M. Said, Ph.D. Senior Medicinal Chemist (Drug Discovery Lead), at NextRNA Therapeutics Inc.-
Acton, Massachusetts, United States
-
Rising Star
Dominique Verhelle Co-founder, President and CEO at NextRNA Therapeutics-
Boston
-
Top 10%
Adam Daniels Student at Northeastern University-
Boston, Massachusetts, United States
-
Rising Star
Overview
NextRNA Therapeutics, Inc. is a MA-based newly founded biotechnology company committed to leading the next revolution of RNA-directed therapeutics. Based on the foundational work of Carl Novina at Dana-Farber Cancer Institute, NextRNA has established a proprietary target and drug discovery engine that enables us to systematically identify disease-relevant long non-coding RNAs and their interacting proteins, and develop selective small molecules to drug RNA-protein interactions. The company is currently advancing two small molecule therapeutic programs in oncology and immunology. NextRNA has assembled a highly experienced and competent team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
-